Stay updated on Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.5, indicating a new release of the page content without altering the study details.
    Difference
    0.0%
    Check dated 2026-06-05T11:23:52.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a small update to the page metadata. This reflects an editorial change to the ClinicalTrials.gov record rather than any substantive study information.
    Difference
    0.0%
    Check dated 2026-05-15T04:21:01.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a new revision label: Revision: v3.5.3, replacing v3.5.2. This signals an update to the page version, with no evident public content changes.
    Difference
    0.0%
    Check dated 2026-04-30T18:50:35.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:16:47.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page. The change does not modify study data or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-03-18T19:22:03.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Site version updated from v3.4.2 to v3.4.3. No observable changes to the study content or user-visible features.
    Difference
    0.0%
    Check dated 2026-03-11T16:55:19.000Z thumbnail image

Stay in the know with updates to Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin/Nab-Paclitaxel + Pembrolizumab in NSCLC Clinical Trial page.